1. Home
  2. CECO vs RCUS Comparison

CECO vs RCUS Comparison

Compare CECO & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CECO
  • RCUS
  • Stock Information
  • Founded
  • CECO 1966
  • RCUS 2015
  • Country
  • CECO United States
  • RCUS United States
  • Employees
  • CECO N/A
  • RCUS N/A
  • Industry
  • CECO Pollution Control Equipment
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CECO Industrials
  • RCUS Health Care
  • Exchange
  • CECO Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • CECO 957.2M
  • RCUS 906.4M
  • IPO Year
  • CECO N/A
  • RCUS 2018
  • Fundamental
  • Price
  • CECO $30.34
  • RCUS $9.35
  • Analyst Decision
  • CECO Strong Buy
  • RCUS Buy
  • Analyst Count
  • CECO 5
  • RCUS 9
  • Target Price
  • CECO $36.00
  • RCUS $20.86
  • AVG Volume (30 Days)
  • CECO 271.8K
  • RCUS 1.1M
  • Earning Date
  • CECO 07-29-2025
  • RCUS 08-07-2025
  • Dividend Yield
  • CECO N/A
  • RCUS N/A
  • EPS Growth
  • CECO 273.86
  • RCUS N/A
  • EPS
  • CECO 1.30
  • RCUS N/A
  • Revenue
  • CECO $608,298,000.00
  • RCUS $141,000,000.00
  • Revenue This Year
  • CECO $32.90
  • RCUS N/A
  • Revenue Next Year
  • CECO $9.01
  • RCUS $28.73
  • P/E Ratio
  • CECO $22.71
  • RCUS N/A
  • Revenue Growth
  • CECO 8.89
  • RCUS N/A
  • 52 Week Low
  • CECO $17.57
  • RCUS $6.50
  • 52 Week High
  • CECO $35.16
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • CECO 59.44
  • RCUS 51.09
  • Support Level
  • CECO $29.49
  • RCUS $8.03
  • Resistance Level
  • CECO $30.26
  • RCUS $8.81
  • Average True Range (ATR)
  • CECO 0.95
  • RCUS 0.43
  • MACD
  • CECO -0.05
  • RCUS -0.00
  • Stochastic Oscillator
  • CECO 74.35
  • RCUS 89.58

About CECO CECO Environmental Corp.

CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: